Using RT-PCR and immunohistochemical staining, previous studies have shown that changes in APE1 expression levels and/or patterns in NSCLC tissues and peripheral blood occurred in the early period of tumorigenesis and were closely related to tumor development, progress, and unfavorable prognosis [31], [45], [46]. The gene discussed is APEX1; the disease is neoplasm.